15 Central Park West penthouse sells for $46.7M
Biopharma CEO Lindsay Rosenwald unloads spacious duplex that he “just wasn’t using”
A sprawling penthouse at 15 Central Park West sold on Tuesday for $46.67 million, 28 percent less than its first asking price.
The 5,902-square-foot duplex is on the 18th and 19th floors of the renowned condominium designed by architect Robert A.M. Stern.
The property went into contract and closed in one day to an unknown buyer who purchased the unit through a Delaware-registered limited liability company.
The seller was Dr. Lindsay Rosenwald, the chief executive of pharmaceutical company Fortress Biotech. He bought the unit in 2008 for $30.5 million and put it on the market in September 2019 for $65 million.
Listing broker Felise Gross of Brown Harris Stevens said Rosenwald listed the penthouse because he “just wasn’t using it.”
The unit’s 19 months on the market included three months early in the pandemic when home showings were banned, but the length of the listing likely had more to do with aspirational pricing and doubts about Manhattan and its luxury market, which has only recently begun to recover from a multi-year slump.
The transaction also included a studio apartment for staff, a wine cellar and two storage units.
Gross, who represented Rosenwald with BHS brokers David Kornmeier and Diane Abrams, dropped the asking price in January by 11 percent to $57.9 million. Though the final sales price was more than $11 million lower, Gross said the doctor was happy with the deal. He received $16 million more for the duplex than he paid.
“In this market I think the seller was very happy and he did very well,” she said. “The apartment is one of the finest in New York.”
The unit has an internal private elevator, five bedrooms, 1,070 square feet of outdoor terraces overlooking Central Park, a gas fireplace and south- and west-facing views.
Sales in Manhattan have picked up in recent months as sellers and developers accept discounted offers from buyers aiming to capitalize on the moment.